PharmVar GeneFocus: CYP2A6
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Alec W R Langlois und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2A6. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, Canadian Institutes of Health Research (CIHR) Project grant, Canadian Institutes of Health Research (CIHR) Foundation grant.
Abstract (Originalsprache)
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the human CYP2A gene locus containing the highly polymorphic CYP2A6 gene. CYP2A6 plays a role in the metabolism of nicotine and various drugs. Thus, genetic variation can substantially contribute to the function of this enzyme and associated efficacy and safety. This GeneFocus provides an overview of the clinical significance of CYP2A6 , including its genetic variation and function. We also highlight and discuss caveats in the identification and characterization of allelic variation of this complex pharmacogene, a prerequisite for accurate genotype determination and prediction of phenotype status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- PharmGenetix GmbH, Niederalm, Austria.
- Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
ORCID-Profile: Alec W R Langlois, Meghan J Chenoweth, David Twesigomwe, Giada Scantamburlo, Michelle Whirl-Carrillo, Katrin Sangkuhl, Teri E Klein, Charity Nofziger, Rachel F Tyndale, Andrea Gaedigk
Förderung
- NHGRI NIH HHS
- Canadian Institutes of Health Research (CIHR) Project grant
- Canadian Institutes of Health Research (CIHR) Foundation grant
- NIH HHS
- Sydney Brenner Charitable Trust
- Canadian Institutes of Health Research
- National Institutes of Health
Zitieren
APA
Langlois, A. W. R., Chenoweth, M. J., Twesigomwe, D., Scantamburlo, G., Whirl-Carrillo, M., Sangkuhl, K., Klein, T. E., Nofziger, C., Tyndale, R. F., & Gaedigk, A. (2024). PharmVar GeneFocus: CYP2A6. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3387
Vancouver
Langlois AWR, Chenoweth MJ, Twesigomwe D, Scantamburlo G, Whirl-Carrillo M, Sangkuhl K, et al. PharmVar GeneFocus: CYP2A6. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3387
BibTeX
@article{Langlois2024,
author = {Langlois, Alec W R and Chenoweth, Meghan J and Twesigomwe, David and Scantamburlo, Giada and Whirl-Carrillo, Michelle and Sangkuhl, Katrin and Klein, Teri E and Nofziger, Charity and Tyndale, Rachel F and Gaedigk, Andrea},
title = {PharmVar GeneFocus: CYP2A6},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3387}
}
EUVIMED